Publications Clinical Highlights: November 2024 Your monthly source for drug information highlights. November 27, 2024 Weight Management Corner: catch up on recent publications and study findings...

cover image for The evolution of GLP-1s Developing a holistic, individualized strategy to capitalize on opportunities and outcomes Prime Therapeutics /the-evolution-of-glp-1s About Prime...

Prime Therapeutics Report shares more about single-treatment gene therapies and proper management

Gene therapy harnesses the body’s capacity to heal itself

Publications Clinical Highlights: February 2025 Your monthly source for drug information highlights. February 28, 2025 Trending topics The annual report Cancer statistics, 2025 from the American...

New report explores traditional, specialty therapy trend impact to employers

Breadcrumb Home Newsroom Custom Content Publications Clinical Highlights: September 2024 PUBLICATIONS Clinical Highlights: September 2024 Your monthly source for drug information highlights....

Studies include Prime’s GLP-1 obesity research and a Medicare drug cost predictive model

A roundup of Prime's award-winning presentations and insights at AMCP Annual Meeting in Houston

Industry experts share new insights from PBM industry, including GLP-1 weight-loss drugs, biosimilars and rising pharmaceutical costs

Critical updates in an ever-changing environment.

Critical updates in an ever-changing environment

Learn with Biosimilar Basics. Part 2 covers biosimilar naming conventions and other nomenclature including common drug pipeline content acronyms.

Read Clinical News: April 2024 Your monthly source for drug information highlights Clinical News Your monthly source for drug information highlights Hot topics NEW PRESCRIPTION DIGITAL THERAPEUTIC...

Breadcrumb Prime Therapeutics Newsroom Custom Content Publications Clinical Highlights: October 2024 Publications Clinical Highlights: October 2024 Your monthly source for drug information...

Read Clinical News: May 2024 Your monthly source for drug information highlights Clinical News Your monthly source for drug information highlights Hot topics FDA ALERT ON PREGNANCY RISKS WITH...

Publications Clinical Highlights: December 2024 Your monthly source for drug information highlights. December 30, 2024 Weight Management Corner An analysis published in The Lancet details national-...

This monthly approval update provides a review of newly approved specialty drugs, recent drug launches, generic updates, new indications and news of note on drugs in the approval process.

Publications Clinical Highlights: January 2025 Your monthly source for drug information highlights. January 30, 2025 Weight management corner The Lancet Diabetes & Endocrinology Commission has...

Read Clinical News: August 2024 Your monthly source for drug information highlights Clinical News Your monthly source for drug information highlights Hot topics FDA SAFETY ALERT ON COMPOUNDED...

In this episode, Prime/MRx clinicians — along with special guests — discuss the hottest topics covered at the Academy of Managed Care Pharmacy (AMCP)'s 2024 Annual Meeting in New Orleans

Perspectives High-Cost Therapy Profile: January Detailed information about Atidarsagene Autotemcel Intravenous (IV) High Cost Therapy Profile Atidarsagene Autotemcel Intravenous (IV) Orchard ...

More than 300 pharma representatives attended this annual gathering to learn more about what Prime/MRx has to offer

Journal of Managed Care & Specialty Pharmacy (JMCP)

A roundup of Prime's award-winning presentations and insights at AMCP Nexus in Las Vegas.

Read Clinical News: June 2024 Your monthly source for drug information highlights Clinical News Your monthly source for drug information highlights Hot topics MDMA-ASSISTED THERAPY FOR PTSD...

Hear some of the latest insights from the annual managed care pharmacy event, where Prime Therapeutics clinical and health outcomes teams presented leading research findings

Identifying and managing diabetes and weight loss therapies earns AMCP platinum award

Publications Clinical Highlights: March 2025 Your monthly source for drug information highlights. March 27, 2025 Trending topics As of late February 2025, the United States (U.S.) Centers for...

This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty drugs, new indications and recent first-time generic launches.

This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty drugs, new indications and recent first-time generic launches.

This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty drugs, new indications and recent first-time generic launches.

Read Drug Approvals Monthly Update: January 2024 Critical updates in an ever-changing environment. Drug Approval Update Specialty New drugs 12/22/2023 Wainua™ (eplontersen) The United States (U.S.)...

Read Drug Approvals Monthly Update: February 2024 This monthly approval update provides a review of newly approved specialty drugs, recent drug launches, generic updates, new indications and news...

Annual conference gathers 2,500+ managed care leaders to discuss complex health care issues.

publications Spring 2024 Prime Therapeutics Report March 15, 2024 The Prime Therapeutics Report is your source for innovative managed care strategies, trends and updates. Our cover story (Page 6)...

13th annual report the preeminent source for medical benefit drug trend

Managed Healthcare Executive

Breadcrumb Home Newsroom Custom Content Publications Drug Approvals Monthly Update: September 2024 PUBLICATIONS Drug Approvals Monthly Update: September 2024 This monthly update of United States...

publications High-Cost Therapy Profile: March 2025 Pegzilarginase Intravenous (IV), Subcutaneous (SC) | Immedica Metabolic March 14, 2025 Proposed indications Arginase 1 deficiency (ARG1-D)...